Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
01 Aug 2019
Historique:
received: 16 01 2019
revised: 07 03 2019
accepted: 15 04 2019
pubmed: 10 5 2019
medline: 27 8 2019
entrez: 10 5 2019
Statut: ppublish

Résumé

Gene fusions involving neuregulin 1 ( Forty-seven patients with pancreatic ductal adenocarcinoma received comprehensive whole-genome and transcriptome sequencing and analysis. Two patients with gene fusions involving Three of 47 (6%) patients with advanced pancreatic ductal adenocarcinoma were identified as This work adds to a growing body of evidence that

Identifiants

pubmed: 31068372
pii: 1078-0432.CCR-19-0191
doi: 10.1158/1078-0432.CCR-19-0191
doi:

Substances chimiques

KRAS protein, human 0
NRG1 protein, human 0
Neuregulin-1 0
Oncogene Proteins, Fusion 0
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4674-4681

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2019 American Association for Cancer Research.

Auteurs

Martin R Jones (MR)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Laura M Williamson (LM)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

James T Topham (JT)

Pancreas Centre British Columbia, Vancouver, Canada.

Michael K C Lee (MKC)

BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.

Angela Goytain (A)

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.

Julie Ho (J)

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.

Robert E Denroche (RE)

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

GunHo Jang (G)

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Erin Pleasance (E)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Yaoquing Shen (Y)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Joanna M Karasinska (JM)

Pancreas Centre British Columbia, Vancouver, Canada.

John P McGhie (JP)

BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.

Sharlene Gill (S)

BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.

Howard J Lim (HJ)

BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.

Malcolm J Moore (MJ)

Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Hui-Li Wong (HL)

BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.

Tony Ng (T)

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.

Stephen Yip (S)

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.

Wei Zhang (W)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Sara Sadeghi (S)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Carolyn Reisle (C)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Andrew J Mungall (AJ)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Karen L Mungall (KL)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Richard A Moore (RA)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Yussanne Ma (Y)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.

Jennifer J Knox (JJ)

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Steven Gallinger (S)

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Janessa Laskin (J)

BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.

Marco A Marra (MA)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

David F Schaeffer (DF)

Pancreas Centre British Columbia, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.

Steven J M Jones (SJM)

BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Molecular Biology and Biochemistry, Simon Fraser University, Vancouver, British Columbia, Canada.

Daniel J Renouf (DJ)

Pancreas Centre British Columbia, Vancouver, Canada. drenouf@bccancer.bc.ca.
BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH